
Sign up to save your podcasts
Or


Everett Millman, precious metals specialist with Gainesville Coins, on his outlook for gold and precious metals. "Banker to the World" Bill Rhodes, former Chairman of Citibank and President and CEO of William Rhodes Global Advisors, on the G20 and China economy. Sam Fazeli, Senior Pharmaceutical Analyst and Head of EMEA Research at Bloomberg Intelligence, on AstraZeneca's vaccine data showing 70-90% effectiveness. Hosted by Paul Sweeney and Vonnie Quinn.
See omnystudio.com/listener for privacy information.
By Bloomberg3.8
381381 ratings
Everett Millman, precious metals specialist with Gainesville Coins, on his outlook for gold and precious metals. "Banker to the World" Bill Rhodes, former Chairman of Citibank and President and CEO of William Rhodes Global Advisors, on the G20 and China economy. Sam Fazeli, Senior Pharmaceutical Analyst and Head of EMEA Research at Bloomberg Intelligence, on AstraZeneca's vaccine data showing 70-90% effectiveness. Hosted by Paul Sweeney and Vonnie Quinn.
See omnystudio.com/listener for privacy information.

976 Listeners

1,167 Listeners

2,184 Listeners

423 Listeners

971 Listeners

196 Listeners

1,037 Listeners

188 Listeners

69 Listeners

1,308 Listeners

65 Listeners

78 Listeners

30 Listeners

60 Listeners

5 Listeners

58 Listeners

233 Listeners

232 Listeners

67 Listeners

83 Listeners

77 Listeners

76 Listeners

87 Listeners

399 Listeners

18 Listeners

13 Listeners

7 Listeners

2 Listeners

115 Listeners

23 Listeners